시장보고서
상품코드
1150063

세계의 울혈성심부전 시장-시장 점유율, 규모, 동향, 산업 분석 : 제품별, 최종 용도별, 지역별, 부문 예측(2022-2030년)

Congestive Heart Failure Market Share, Size, Trends, Industry Analysis Report, By Product ; By End-Use; By Region; Segment Forecast, 2022 - 2030

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 울혈성심부전 시장 규모는 2030년까지 184억 8,000만 달러에 달할 것으로 예측됩니다.

세계의 울혈성심부전(Congestive Heart Failure) 시장을 조사했으며, 시장 개요/시장 규모 및 예측/동향/촉진 요인·억제 요인/제품별·최종 용도별·지역별 분석/기업 개요 등 를 제공합니다.

목차

제1장 소개

  • 리포트 설명
    • 조사의 목적
    • 시장 범위
    • 전제 조건
  • 이해관계자

제2장 주요 요약

  • 시장의 하이라이트

제3장 조사 방법

  • 개요
    • 데이터 마이닝
  • 정보원
    • 1차 정보
    • 2차 정보

제4장 세계의 울혈성심부전 시장 통찰

  • 울혈성심부전 시장-산업 스냅샷
  • 울혈성심부전 시장 역학
    • 촉진 요인과 기회
    • 억제 요인과 과제
  • Porter’s Five Forces
    • 공급기업의 협상력
    • 신규 참가자의 위협
    • 구매자의 협상력
    • 대체품의 위협
    • 기존 기업 간의 경쟁력
  • PESTLE 분석
  • 울혈성심부전의 산업 동향
  • 밸류체인 분석
  • COVID-19 영향 분석

제5장 세계의 울혈성심부전 시장 : 제품별

  • 주요 조사 결과
  • 소개
    • 세계의 울혈성심부전, 제품별(2018-2030년)
  • 심실 보조 장치
    • 세계의 울혈성심부전 시장, 심실 보조 장치별, 지역별(2018-2030년)
  • 이식형 제세동기(ICD)
    • 세계의 울혈성심부전 시장, 이식형 제세동기(ICD)별, 지역별(2018-2030년)
  • 페이스 제조사
    • 세계의 울혈성심부전 시장, 페이스 제조사별, 지역별(2018-2030년)
  • 심장 재동기 요법
    • 세계의 울혈성심부전 시장, 심장 재동기 요법별, 지역별(2018-2030년)
  • 카운터 펄세이션 디바이스
    • 세계의 울혈성심부전 시장, 카운터 펄세이션 디바이스별, 지역별(2018-2030년)

제6장 세계의 울혈성심부전 시장 : 최종 용도별

  • 주요 조사 결과
  • 소개
    • 세계의 울혈성심부전 시장, 최종 용도별(2018-2030년)
  • 병원·클리닉
    • 세계의 울혈성심부전 시장, 병원·클리닉별, 지역별(2018-2030년)
  • 심혈관 질환 전문 치료 센터
    • 세계의 울혈성심부전 시장, 심혈관 질환 전문 치료 센터별, 지역별(2018-2030년)
  • 외래 수술 센터
    • 세계의 울혈성심부전 시장, 외래 수술 센터별, 지역별(2018-2030년)

제7장 세계의 울혈성심부전 시장 : 지역별

  • 주요 조사 결과
  • 소개
    • 울혈성심부전 시장의 평가, 지역별(2018-2030년)
  • 울혈성심부전 시장-북미
    • 북미 : 울혈성심부전 시장, 최종 용도별(2018-2030년)
    • 북미 : 울혈성심부전 시장, 제품별(2018-2030년)
    • 울혈성심부전 시장-미국
    • 울혈성심부전 시장-캐나다
  • 울혈성심부전 시장-유럽
    • 유럽 : 울혈성심부전 시장, 최종 용도별(2018-2030년)
    • 유럽 : 울혈성심부전 시장, 제품별(2018-2030년)
    • 울혈성심부전 시장-영국
    • 울혈성심부전 시장-프랑스
    • 울혈성심부전 시장-독일
    • 울혈성심부전 시장-이탈리아
    • 울혈성심부전 시장-스페인
    • 울혈성심부전 시장-네덜란드
    • 울혈성심부전 시장-러시아
  • 울혈성심부전 시장-아시아 태평양
    • 아시아 태평양 : 울혈성심부전 시장, 최종 용도별(2018-2030년)
    • 아시아 태평양 : 울혈성심부전 시장, 제품별(2018-2030년)
    • 울혈성심부전 시장-중국
    • 울혈성심부전 시장-인도
    • 울혈성심부전 시장-말레이시아
    • 울혈성심부전 시장-일본
    • 울혈성심부전 시장-인도네시아
    • 울혈성심부전 시장-한국
  • 울혈성심부전 시장-중동·아프리카
    • 중동·아프리카 : 울혈성심부전 시장, 최종 용도별(2018-2030년)
    • 중동·아프리카 : 울혈성심부전 시장, 제품별(2018-2030년)
    • 울혈성심부전 시장-사우디 아라비아
    • 울혈성심부전 시장-아랍 에미리트 연방
    • 울혈성심부전 시장-이스라엘
    • 울혈성심부전 시장-남아프리카
  • 울혈성심부전 시장-남미
    • 남미 : 울혈성심부전 시장, 최종 용도별(2018-2030년)
    • 남미 : 울혈성심부전 시장, 제품별(2018-2030년)
    • 울혈성심부전 시장-멕시코
    • 울혈성심부전 시장-브라질
    • 울혈성심부전 시장-아르헨티나

제8장 경쟁 상황

  • 확대·인수 분석
    • 확대
    • 인수
  • 파트너십/협업/협정/전시

제9장 기업 개요

  • ABIOMED
  • Berlin Heart
  • Abbot Laboratories
  • Aspect Imaging Ltd
  • Siemens
  • General Electric
  • Hitachi
  • Koninklijke Philips
  • Neusoft Corporation
  • ESAOTE
  • Medtronic
  • OMRON Corporation
  • Dexcom
  • Masimo
  • Jarvik Heart
  • Biotronik
  • Teleflex
  • Jude Medical
  • Lepu Medical
  • Osypka Medical GmbH
  • Medtronic
  • Boston Scientific Corporation
LYJ 22.11.30

The global congestive heart failure market size is expected to reach USD 18.48 billion by 2030, according to a new study by Polaris Market Research. The report "Congestive Heart Failure Market Share, Size, Trends, Industry Analysis Report, By Product (Cardiac Resynchronization Therapy, Counter Pulsation Devices, ICD, Pacemakers, Ventricular Assist Devices, Others); By End-Use; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Congestive heart failure is becoming more prevalent, in part due to the rise in coronary artery disease and heart attacks worldwide. According to the World Health Organization's 2021 report, cardiovascular diseases (CVDs), which accounted for 17.9 million deaths worldwide in 2019 (32% of all fatalities), were the cause of 32% of all deaths. Furthermore, the American Heart Association predicts that by 2030, even more Americans than the present 22.2 million will have heart disease.

Due to the rising prevalence of CVDs and the increased need for treatment devices, the market will soon grow. Market leaders take part in new launches, partnerships, expansions, and acquisitions to stay competitive. For instance, Abbott's EnSite X EP System, which uses EnSite omnipolar technology to treat cardiac arrhythmias, received FDA approval in the U.S., in January 2022.

COVID-19 pandemic reportedly had a negative impact on people with underlying cardiovascular disease, particularly those who had previously experienced an acute cardiac injury. A research by Tarun Dalia et al., published in February 2021, found that congestive heart failure (CHF), which is present in individuals with COVID-19, is related to worse outcomes and higher mortality. Additionally, cardiac arrhythmia and abrupt cardiac injury are more likely to occur in people who have severe COVID-19 and non-survivor circumstances.

An increase in cardiovascular patients, an ageing population, insurance coverage, and technological developments like proprietary algorithms that accurately detect and reduce the incidence of atrial fibrillation are some of the main factors influencing the growth of implantable pacemakers. According to the United Nations Department of Economic and Social Affairs' research on world population ageing.

In 2020, there were 727 million people over the age of 65 in the world. Over the next three decades, the number of older people worldwide is predicted to more than quadruple, reaching over 1.5 billion in 2050. This is because an ageing population is more prone to chronic diseases, such as cardiovascular diseases, which are likely to increase during the projection period.

Congestive Heart Failure Market Report Highlights

In 2021, the market for congestive heart failure is expected to be dominated by pacemaker devices. Congestive heart failure therapeutic devices for the treatment of heart failure are in higher demand, pacemaker use is increasing, and pharmaceutical and medical device R&D are all contributing to the expansion of this market.

In 2021, hospital systems made up the majority of this market. This hospital segment has expanded as a result of the rising patient population and the significant concentration of trained workers in hospital settings. Additionally, hospitals support the reduction of adverse patient reactions during crucial medical procedures.

The majority of the market was controlled by North America. Rising cases of target illnesses, better public knowledge of the heart related ailments are few regional drivers.

The global players with global presence include ABIOMED, LivaNova, Jarvik Heart Inc., Berlin Heart, Abbot Laboratories, Aspect Imaging Ltd, CANON MEDICAL SYSTEMS CORPORATION, and Siemens.

Polaris Market Research has segmented the congestive heart failure market report based on product, end-use, and region:

Congestive Heart Failure, Product Outlook (Revenue - USD Billion, 2018 - 2030)

Ventricular Assist Devices

Implantable Cardioverter Defibrillators (ICD)

Pacemakers

Cardiac Resynchronization Therapy

Counter Pulsation Devices

Congestive Heart Failure, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Hospitals and clinic

Specialized Cardiovascular Disease Treatment centers

Ambulatory surgery centers

Congestive Heart Failure, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Congestive Heart Failure Market Insights

  • 4.1. Congestive Heart Failure Market - Industry Snapshot
  • 4.2. Congestive Heart Failure Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising prevalence of cardiovascular diseases (CVD)
      • 4.2.1.2. Growing geriatric population base
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of devices
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Congestive Heart Failure Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Congestive Heart Failure Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Congestive Heart Failure, by Product, 2018 - 2030 (USD Billion)
  • 5.3. Ventricular Assist Devices
    • 5.3.1. Global Congestive Heart Failure Market, by Ventricular Assist Devices, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Implantable Cardioverter Defibrillators (ICD)
    • 5.4.1. Global Congestive Heart Failure Market, by Implantable Cardioverter Defibrillators (ICD), by Region, 2018 - 2030 (USD Billion)
  • 5.5. Pacemakers
    • 5.5.1. Global Congestive Heart Failure Market, by Pacemakers, by Region, 2018 - 2030 (USD Billion)
  • 5.6. Cardiac Resynchronization Therapy
    • 5.6.1. Global Congestive Heart Failure Market, by Cardiac Resynchronization Therapy, by Region, 2018 - 2030 (USD Billion)
  • 5.7. Counter Pulsation Devices
    • 5.7.1. Global Congestive Heart Failure Market, by Counter Pulsation Devices, by Region, 2018 - 2030 (USD Billion)

6. Global Congestive Heart Failure Market, by End-Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  • 6.3. Hospitals & Clinic
    • 6.3.1. Global Congestive Heart Failure Market, by Hospitals & Clinic, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Specialized Cardiovascular Disease Treatment Centres
    • 6.4.1. Global Congestive Heart Failure Market, by Specialized Cardiovascular Disease Treatment Centres, by Region, 2018 - 2030 (USD Billion)
  • 6.5. Ambulatory Surgery Centres
    • 6.5.1. Global Congestive Heart Failure Market, by Ambulatory Surgery Centres, by Region, 2018 - 2030 (USD Billion)

7. Global Congestive Heart Failure Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Congestive Heart Failure Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 7.3. Congestive Heart Failure Market - North America
    • 7.3.1. North America: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
    • 7.3.2. North America: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.3.3. Congestive Heart Failure Market - U.S.
      • 7.3.3.1. U.S.: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.3.3.2. U.S.: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.3.4. Congestive Heart Failure Market - Canada
      • 7.3.4.1. Canada: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.3.4.2. Canada: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
  • 7.4. Congestive Heart Failure Market - Europe
    • 7.4.1. Europe: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
    • 7.4.2. Europe: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.4.3. Congestive Heart Failure Market - UK
      • 7.4.3.1. UK: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.4.3.2. UK: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.4.4. Congestive Heart Failure Market - France
      • 7.4.4.1. France: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.4.4.2. France: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.4.5. Congestive Heart Failure Market - Germany
      • 7.4.5.1. Germany: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.4.5.2. Germany: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.4.6. Congestive Heart Failure Market - Italy
      • 7.4.6.1. Italy: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.4.6.2. Italy: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.4.7. Congestive Heart Failure Market - Spain
      • 7.4.7.1. Spain: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.4.7.2. Spain: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.4.8. Congestive Heart Failure Market - Netherlands
      • 7.4.8.1. Netherlands: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.4.8.2. Netherlands: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.4.9. Congestive Heart Failure Market - Russia
      • 7.4.9.1. Russia: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.4.9.2. Russia: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
  • 7.5. Congestive Heart Failure Market - Asia Pacific
    • 7.5.1. Asia Pacific: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
    • 7.5.2. Asia Pacific: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.5.3. Congestive Heart Failure Market - China
      • 7.5.3.1. China: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.5.3.2. China: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.5.4. Congestive Heart Failure Market - India
      • 7.5.4.1. India: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.5.4.2. India: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.5.5. Congestive Heart Failure Market - Malaysia
      • 7.5.5.1. Malaysia: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.5.5.2. Malaysia: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.5.6. Congestive Heart Failure Market - Japan
      • 7.5.6.1. Japan: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.5.6.2. Japan: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.5.7. Congestive Heart Failure Market - Indonesia
      • 7.5.7.1. Indonesia: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.5.7.2. Indonesia: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.5.8. Congestive Heart Failure Market - South Korea
      • 7.5.8.1. South Korea: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.5.8.2. South Korea: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
  • 7.6. Congestive Heart Failure Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
    • 7.6.2. Middle East & Africa: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.6.3. Congestive Heart Failure Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.6.4. Congestive Heart Failure Market - UAE
      • 7.6.4.1. UAE: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.6.4.2. UAE: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.6.5. Congestive Heart Failure Market - Israel
      • 7.6.5.1. Israel: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.6.5.2. Israel: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.6.6. Congestive Heart Failure Market - South Africa
      • 7.6.6.1. South Africa: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.6.6.2. South Africa: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
  • 7.7. Congestive Heart Failure Market - Latin America
    • 7.7.1. Latin America: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
    • 7.7.2. Latin America: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.7.3. Congestive Heart Failure Market - Mexico
      • 7.7.3.1. Mexico: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.7.3.2. Mexico: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.7.4. Congestive Heart Failure Market - Brazil
      • 7.7.4.1. Brazil: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.7.4.2. Brazil: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
    • 7.7.5. Congestive Heart Failure Market - Argentina
      • 7.7.5.1. Argentina: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
      • 7.7.5.2. Argentina: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. ABIOMED
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Berlin Heart
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Abbot Laboratories
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Aspect Imaging Ltd
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Siemens
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. General Electric
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Hitachi
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Koninklijke Philips
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Neusoft Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. ESAOTE
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Medtronic
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. OMRON Corporation
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Dexcom
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Masimo
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Jarvik Heart
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development
  • 9.16. Biotronik
    • 9.16.1. Company Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Recent Development
  • 9.17. Teleflex
    • 9.17.1. Company Overview
    • 9.17.2. Financial Performance
    • 9.17.3. Product Benchmarking
    • 9.17.4. Recent Development
  • 9.18. Jude Medical
    • 9.18.1. Company Overview
    • 9.18.2. Financial Performance
    • 9.18.3. Product Benchmarking
    • 9.18.4. Recent Development
  • 9.19. Lepu Medical
    • 9.19.1. Company Overview
    • 9.19.2. Financial Performance
    • 9.19.3. Product Benchmarking
    • 9.19.4. Recent Development
  • 9.20. Osypka Medical GmbH
    • 9.20.1. Company Overview
    • 9.20.2. Financial Performance
    • 9.20.3. Product Benchmarking
    • 9.20.4. Recent Development
  • 9.21. Medtronic
    • 9.21.1. Company Overview
    • 9.21.2. Financial Performance
    • 9.21.3. Product Benchmarking
    • 9.21.4. Recent Development
  • 9.22. Boston Scientific Corporation
    • 9.22.1. Company Overview
    • 9.22.2. Financial Performance
    • 9.22.3. Product Benchmarking
    • 9.22.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제